(Q80131188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Long-term treatment with long-acting risperidone in Korean patients with schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

9

In-Kwa Jung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

6

Sook-Haeng Joe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Moon-Soo Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Young-Hoon Ko

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sang-Hoon Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Yong-Jin Seo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Seung-Hyun Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Chang-Su Han

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jung-Ho Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

published in

Human Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

399-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

28 December 2019

cites work

1 reference

7 January 2021

Evaluating quality-of-life measures for clinical trials in Germany

1 reference

7 January 2021

Depot antipsychotic drugs. Place in therapy

1 reference

7 January 2021

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic

1 reference

7 January 2021

Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year

1 reference

7 January 2021

Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine

1 reference

7 January 2021

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

7 January 2021

Guidelines for depot antipsychotic treatment in schizophrenia

1 reference

7 January 2021

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

1 reference

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

7 January 2021

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

1 reference

7 January 2021

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

1 reference

7 January 2021

Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia

1 reference

7 January 2021

Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone

1 reference

7 January 2021

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies

1 reference

7 January 2021

1 reference

7 January 2021

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

1 reference

7 January 2021

Prognostic variables at intake and long-term level of function in schizophrenia.

1 reference

7 January 2021

Towards consensus in the long-term management of relapse prevention in schizophrenia

1 reference

7 January 2021

Social outcomes in schizophrenia: from description to action

1 reference

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

7 January 2021

Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.782

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16915580%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference